VAS
CRL icon

Vestmark Advisory Solutions’s Charles River Laboratories CRL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-41,820
Closed -$6.29M 782
2025
Q1
$6.29M Buy
41,820
+18,252
+77% +$2.75M 0.16% 165
2024
Q4
$4.35M Sell
23,568
-2,196
-9% -$405K 0.15% 148
2024
Q3
$5.07M Buy
25,764
+2,219
+9% +$437K 0.19% 110
2024
Q2
$4.86M Buy
23,545
+4,086
+21% +$844K 0.2% 108
2024
Q1
$5.27M Buy
19,459
+1,339
+7% +$363K 0.23% 105
2023
Q4
$4.28M Buy
18,120
+1,231
+7% +$291K 0.22% 116
2023
Q3
$3.31M Sell
16,889
-21,481
-56% -$4.21M 0.24% 98
2023
Q2
$8.07M Buy
38,370
+1,434
+4% +$301K 0.31% 77
2023
Q1
$7.45M Buy
36,936
+1,561
+4% +$315K 0.32% 67
2022
Q4
$7.71M Sell
35,375
-795
-2% -$173K 0.38% 51
2022
Q3
$7.12M Buy
36,170
+2,734
+8% +$538K 0.4% 45
2022
Q2
$7.15M Buy
33,436
+4,209
+14% +$901K 0.41% 43
2022
Q1
$8.3M Buy
29,227
+3,815
+15% +$1.08M 0.47% 32
2021
Q4
$9.58M Buy
25,412
+3,299
+15% +$1.24M 0.54% 28
2021
Q3
$9.13M Buy
22,113
+2,190
+11% +$904K 0.62% 23
2021
Q2
$7.37M Buy
19,923
+1,868
+10% +$691K 0.52% 30
2021
Q1
$5.23M Buy
18,055
+6,376
+55% +$1.85M 0.46% 34
2020
Q4
$2.92M Buy
11,679
+966
+9% +$241K 0.33% 73
2020
Q3
$2.43M Buy
10,713
+1,330
+14% +$301K 0.33% 78
2020
Q2
$1.64M Buy
9,383
+756
+9% +$132K 0.25% 120
2020
Q1
$1.09M Buy
+8,627
New +$1.09M 0.21% 150
2019
Q4
Sell
-7,567
Closed -$1M 313
2019
Q3
$1M Buy
7,567
+2,582
+52% +$342K 0.16% 184
2019
Q2
$707K Buy
4,985
+319
+7% +$45.2K 0.12% 224
2019
Q1
$678K Buy
+4,666
New +$678K 0.12% 231